The Women and Infant Health Program at the Wyoming Department of Health is focusing on prevention of preterm birth as part of our efforts to reduce infant mortality. We are conducting a survey of Wyoming providers to learn about the use of progesterone therapy, 17 alpha-hydroxyprogesterone caproate (17P), to prevent recurrent preterm delivery (in women with a prior spontaneous singleton preterm birth) and to better understand any existing barriers to its use in Wyoming.
Thank you for your time and effort in completing the survey. Please add any additional comments that would further inform us about your experience using progesterone therapy. If you have any questions, please contact Ashley Busacker at email@example.com 307-777-6936, or Danielle Marks Danielle.firstname.lastname@example.org 307-777-7944.